Diabetes

Young children in some provinces get help from trained school personnel—often teaching assistants—in using their insulin pumps during the school day. But that's not the case in Manitoba.

Comprehensive JAMA review highlights pathophysiology, clinical presentation, causes, diagnosis, management and prognosis.

Systematic review and meta-analyses of real-world evidence examines the association of SGLT2 inhibitors and the risk of infections in patients with type 2 diabetes.

As we enter Diabetes Month, this article looks at ways to foster preparedness and sustainable practices in the face of climate change.

Study compares the risk of developing nonexudative AMD and its progression to exudative AMD in patients with obesity taking GLP-1RAs vs other weight-loss drugs.

Despite the hype surrounding GLP-1 receptor agonists, a significant proportion of patients discontinue treatment after a few months, reducing the chances of long-term benefits.

Study participants who were treated with the GLP-1 inhibitor had a lower risk of dementia, ischemic stroke and all-cause mortality.

Answers to common questions about insulin pump therapy.